Detalles de la búsqueda
1.
The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.
Lancet
; 397(10282): 1363-1374, 2021 04 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33838757
2.
The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.
Lancet
; 397(10282): 1375-1386, 2021 04 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33838758
3.
Linear mixed models to handle missing at random data in trial-based economic evaluations.
Health Econ
; 31(6): 1276-1287, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35368119
4.
Cost-Effectiveness Analysis of Adalimumab for the Treatment of Uveitis Associated with Juvenile Idiopathic Arthritis.
Ophthalmology
; 126(3): 415-424, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30336181
5.
Societal Preferences for Funding Orphan Drugs in the United Kingdom: An Application of Person Trade-Off and Discrete Choice Experiment Methods.
Value Health
; 21(5): 538-546, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29753350
6.
Cost effectiveness analysis of HLA-B*58:01 genotyping prior to initiation of allopurinol for gout.
Rheumatology (Oxford)
; 56(10): 1729-1739, 2017 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28957559
7.
Renal transplant patients' preference for the supply and delivery of immunosuppressants in Wales: a discrete choice experiment.
BMC Nephrol
; 18(1): 305, 2017 Oct 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28969602
8.
Cost-effectiveness of screening for HLA-A*31:01 prior to initiation of carbamazepine in epilepsy.
Epilepsia
; 56(4): 556-63, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26046144
9.
Pharmacogenetic testing prior to carbamazepine treatment of epilepsy: patients' and physicians' preferences for testing and service delivery.
Br J Clin Pharmacol
; 80(5): 1149-59, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26138622
10.
Predictors of self-reported adherence to antihypertensive medicines: a multinational, cross-sectional survey.
Value Health
; 18(2): 206-16, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25773556
11.
Economic evaluation of a behavior-modifying intervention to enhance antiepileptic drug adherence.
Epilepsy Behav
; 45: 180-6, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25819948
12.
13.
Investigating preferences for support with life after stroke: a discrete choice experiment.
BMC Health Serv Res
; 14: 63, 2014 Feb 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-24507804
14.
Supporting People With Type 2 Diabetes in the Effective Use of Their Medicine Through Mobile Health Technology Integrated With Clinical Care to Reduce Cardiovascular Risk: Protocol for an Effectiveness and Cost-effectiveness Randomized Controlled Trial.
JMIR Res Protoc
; 11(2): e32918, 2022 Feb 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35188478
15.
Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
Health Technol Assess
; 25(75): 1-134, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34931602
16.
Study protocol for a pragmatic randomised controlled trial comparing the effectiveness and cost-effectiveness of levetiracetam and zonisamide versus standard treatments for epilepsy: a comparison of standard and new antiepileptic drugs (SANAD-II).
BMJ Open
; 10(8): e040635, 2020 08 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-32847927
17.
Attitudes towards epilepsy in the UK population: Results from a 2018 national survey.
Seizure
; 65: 12-19, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30594807
18.
Cost-Effectiveness of Panel Tests for Multiple Pharmacogenes Associated With Adverse Drug Reactions: An Evaluation Framework.
Clin Pharmacol Ther
; 105(6): 1429-1438, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30466189
19.
Patient-Focused Drug Development Methods for Benefit-Risk Assessments: A Case Study Using a Discrete Choice Experiment for Antiepileptic Drugs.
Clin Pharmacol Ther
; 105(3): 672-683, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30204252
20.
Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT.
Health Technol Assess
; 23(15): 1-140, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31033434